Perspectum partners with SimonMed to expand its impact on liver health and the clinical journey for patients with liver disease

Date
January 13, 2022
Topics
NAFLD, NASH, LiverMultiScan, Liver Disease, liverhealth, Partnership

Dallas, TX., January 13th 2022 – Perspectum is excited to announce its partnership with SimonMed, one of the largest outpatient medical imaging providers in the U.S., to expand clinician and patient access to its best-in-class diagnostic aid LiverMultiScan®.

LiverMultiScan is a non-invasive MRI technology that delivers a clear picture of liver health through three key metrics in one single scan. Its visual, clinically meaningful report enables physicians with early detection, diagnosis, treatment triage and monitoring of liver disease progression.

With the prevalence of liver disease in over 100 million Americans, the ability to identify patients in the early stages at the point where the disease is still reversible is vital to disease management. Many patients do not show obvious symptoms until later stages of the disease, and if left undiagnosed and untreated, it can lead to serious complications such as liver failure, cancer and the need for liver transplant.

“SimonMed continues to utilize the newest in advanced FDA approved AI technology to enhance patient care,” said Dr. John Simon, CEO of SimonMed. “Perspectum supports our efforts, in particular to improve the diagnosis and monitoring of treatment of liver disease, which is widespread and often underdiagnosed in the US.”

SimonMed operates across nine states in over 150 accredited facilities. LiverMultiScan will first be available as part of SimonMed’s latest advanced imaging tool, simonONE. Both SimonMed and Perspectum share a goal of offering rapid and reliable imaging to deliver a more comfortable experience for patients. LiverMultiScan is the first accurate and non-invasive procedure that offers an end-to-end view of the liver, allowing patients and physicians to see more than ever before.

“This partnership supports Perspectum’s mission of leading the way to patient-driven care,” said Teresa Mattarelli, CCO of Perspectum. “The more patients and clinicians we can enable with our cutting-edge technology, the more we can help stop the growing epidemic of liver disease.”

For additional information, please visit:

perspectum.comLinkedInFacebook and Twitter

simonmed.com, LinkedInFacebook, Instagram and Twitter

About Perspectum 

Perspectum, a global medical technology company with offices in the U.K., Portugal, the U.S. and Singapore, delivers leading digital technologies that help clinicians provide better care for patients with chronic metabolic diseases, multi-organ pathology and cancer. With a strong focus on precision medicine using advanced imaging and genetics, our vision is to empower patients and clinicians through quantitative assessments of health enabling early detection, diagnosis and targeted treatment. With a diverse team of physicians, biomedical scientists, engineers and technologists, Perspectum offers a way to manage complex health problems at scale.

About SimonMed

SimonMed is made up of more than 200 highly experienced subspecialty-trained radiologists and operates across eleven states with over 150 accredited facilities that are ACR-RADSITE certified with certified technologists and equipment. The company specializes in using the newest diagnostic imaging technologies and bringing them to the community in an affordable and accessible way.

For further information from Perspectum, please contact:

Michelle Jones
Senior VP Marketing
michelle.jones@perspectum.com